Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Influence of clinical and genetic factors on propofol dose requirements: A genome-wide association study

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 11:07
  • Read more about Influence of clinical and genetic factors on propofol dose requirements: A genome-wide association study

Alzheimer's disease as a causal risk factor for diabetic retinopathy: a Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 05/07/2024 - 11:04
  • Read more about Alzheimer's disease as a causal risk factor for diabetic retinopathy: a Mendelian randomization study

Causal effect of serum matrix metalloproteinase levels on venous thromboembolism: a Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 05/03/2024 - 10:04
  • Read more about Causal effect of serum matrix metalloproteinase levels on venous thromboembolism: a Mendelian randomization study

Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism

Submitted by Frida Mäkelä on Fri, 05/03/2024 - 10:01
  • Read more about Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism

Multiple reports on the causal relationship between various chronic pain and gut microbiota: a two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 05/03/2024 - 09:59
  • Read more about Multiple reports on the causal relationship between various chronic pain and gut microbiota: a two-sample Mendelian randomization study

Causal Association Between Diabetes, Body Mass Index and Lichen Sclerosus: A Bidirectional Two-Sample Mendelian Randomization Analysis

Submitted by Frida Mäkelä on Fri, 05/03/2024 - 09:55
  • Read more about Causal Association Between Diabetes, Body Mass Index and Lichen Sclerosus: A Bidirectional Two-Sample Mendelian Randomization Analysis

Protective effect of higher free thyroxine levels within the reference range on biliary tract cancer risk: a multivariable mendelian randomization and mediation analysis

Submitted by Frida Mäkelä on Tue, 04/30/2024 - 17:29
  • Read more about Protective effect of higher free thyroxine levels within the reference range on biliary tract cancer risk: a multivariable mendelian randomization and mediation analysis

Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 04/30/2024 - 17:22
  • Read more about Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study

Integrative Mendelian Randomization approaches for therapeutic target prioritisation in immune-mediated diseases

Submitted by Frida Mäkelä on Tue, 04/30/2024 - 13:58
  • Read more about Integrative Mendelian Randomization approaches for therapeutic target prioritisation in immune-mediated diseases

The role of mitochondrial DNA copy number in neuropsychiatric disorders: A bidirectional two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 04/30/2024 - 13:53
  • Read more about The role of mitochondrial DNA copy number in neuropsychiatric disorders: A bidirectional two-sample Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 302
  • Page 303
  • Page 304
  • Page 305
  • Current page 306
  • Page 307
  • Page 308
  • Page 309
  • Page 310
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement